Medication info

Plasuo-Phi Injection

Prescription medicationInjectionsIntravenous injection
Ingredient · strength
Sodium Chloride›5.26g / 1000mLSodium Gluconate›5.02g / 1000mLPotassium Chloride›0.37g / 1000mLMagnesium Chloride›0.3g / 1000mLSodium Acetate Hydrate›3.68g / 1000mL
Manufacturer / importer
JW Life Science Co., Ltd.
Appearance
A colorless and transparent injection in a polypropylene or multi-layer film plastic container
Packaging
500mL/bag, 1000mL/bag
Approval status
Active

MFDS item code 200606562 · Notified 2006.11.08 · Insurance code 678900410,678900420

Summary

Main use
Correction of metabolic acidosis and improvement of extracellular fluid volume depletion
Who receives it
Adults
Adult administration
Usually, 500~1,000mL is administered to adults once by intravenous drip. The infusion rate is 200mL per hour. The dose and infusion rate may be adjusted as appropriate according to age, body weight, and symptoms.

Ingredients

Manufacturer
JW Life Science Co., Ltd.

Efficacy & effects

Correction of metabolic acidosis and improvement of extracellular fluid volume depletion

View approved original text

This medicine helps replenish and regulate extracellular fluid when circulating blood volume and interstitial fluid in the body are reduced. It also effectively improves metabolic acidosis, helping to maintain the body's acid-base balance. Therefore, this drug is used to treat blood circulation and acid-base balance disorders.

How it is given

Adult administration

Usually, 500~1,000mL is administered to adults once by intravenous drip. The infusion rate is 200mL per hour. The dose and infusion rate may be adjusted as appropriate according to age, body weight, and symptoms.

Precautions

This medication may cause allergic reactions during use, so if there are signs of hypersensitivity, administration should be discontinued immediately, and appropriate treatment must be sought. As it contains a high amount of potassium, there is a risk of hyperkalemia, so patients with impaired renal function, heart disease, or those taking medications that may raise potassium levels should exercise caution. High sodium and chloride concentrations may lead to electrolyte imbalances such as hypernatremia, hyperchloremic acidosis, and metabolic acidosis. Patients with hypertension, liver disease, or heart failure should be carefully monitored for fluid overload or edema while using this medication. This drug may cause hyponatremia, so special caution is required for children, elderly patients, postoperative patients, and those taking medications that may cause low sodium levels. If symptoms such as headache, vomiting, seizures, or drowsiness occur, it is essential to inform medical personnel immediately, and regular monitoring of serum sodium levels and neurological status should be conducted. Due to the risk of fluid overload, the infusion amount and speed should be adjusted, and fluid balance and electrolyte status should be continuously monitored during prolonged administration. This medication should not be administered to patients with hypervolemia, hypernatremia, or those who have had hypersensitivity reactions to this drug. Careful administration is required in patients with heart failure, renal failure, hyperkalemia, metabolic alkalosis, and impaired liver function, and blood tests and clinical status should be frequently checked if necessary. Local warmth, infection, or thrombosis may occur at the injection site, and rapid administration may cause cerebral edema, pulmonary edema, swelling, and metabolic alkalosis. Since this drug contains sodium, caution is needed when used in conjunction with medications such as corticosteroids that increase sodium retention. The risk increases when used with drugs that cause hyperkalemia, so serum potassium levels must be monitored. Caution is also required when used with lithium, as blood lithium levels may fluctuate. When used with diuretics, anticonvulsants, or psychotropic drugs that pose a risk of hyponatremia, serum sodium levels should be checked frequently.

Side effects

  • Anaphylaxis
  • hyperkalemia
  • hypernatremia
  • hyperchloremia
  • metabolic acidosis
  • hyponatremia
  • headache
  • nausea
  • seizures
  • somnolence
Show 19 more
  • vomiting
  • cerebral edema
  • pulmonary edema
  • peripheral edema
  • metabolic alkalosis
  • warmth at the injection site
  • infection
  • venous thrombosis
  • phlebitis
  • exudate
  • hypervolemia
  • systemic papules and erythema
  • rash
  • hypertension
  • tachycardia
  • hyponatremic encephalopathy
  • cardiac arrest
  • chills
  • pain at the infusion site

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. It is advisable to keep it at room temperature rather than in excessively hot or cold places.

Appearance and packaging

Appearance

A colorless and transparent injection in a polypropylene or multi-layer film plastic container

Package unit

500mL/bag, 1000mL/bag

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.